June 21, 2022
ATLAS and the Weight of Experience
PHRI Senior Scientist Jeff Healey spoke at a webinar today about the results of his trial looking at S-ICD versus...
Read More
June 20, 2022
Race, ethnicity, & ancestry in health research
PHRI Investigators Marie Pigeyre and Matt Lanktree co-hosted the OMICS and Epidemiology conference last week, where presenters explored the challenges...
Read More
June 6, 2022
ADA outstanding achievement award to Hertzel Gerstein
PHRI Deputy Director and Senior Scientist Hertzel Gerstein received the 2022 Outstanding Achievement in Clinical Diabetes Research Award, presented at...
Read More
June 1, 2022
In person again!
Coming together in-person as an organization used to be a regular occurrence for PHRI: research days, lectureships, symposiums and rounds...
Read More
May 30, 2022
Take it to the LIMIT
You know a vanguard study has been very successful when one of its key objectives – assessing recruitment potential – ...
Read More
May 25, 2022
COMPASS LTOLE supports dual pathway inhibition for vascular protection
PHRI’s COMPASS Long Term Open Label Extension (LTOLE) “further highlights and supports long-term use of [Factor Xa inhibitor anticoagulant] rivaroxaban,...
Read More